Pancreatic Diseases: Clinical Trials

6,466 trials for Pancreatic Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3103 completed, 981 unknown, 862 recruiting, 597 terminated. 1698 Phase 2, 1494 Not applicable, 1332 Phase 1, 472 Phase 3, 211 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 21698Completed 802, Terminated 236, Recruiting 208, Unknown 193, Active not recruiting 105, Withdrawn 72, Not yet recruiting 67, Suspended 13, Enrolling by invitation 2
Not applicable1494Completed 674, Unknown 307, Recruiting 191, Terminated 102, Not yet recruiting 87, Withdrawn 62, Active not recruiting 55, Enrolling by invitation 9, Suspended 7
Phase 11332Completed 668, Terminated 178, Recruiting 175, Unknown 114, Active not recruiting 88, Withdrawn 59, Not yet recruiting 36, Suspended 14
Phase 3472Completed 272, Terminated 52, Recruiting 49, Unknown 49, Active not recruiting 19, Not yet recruiting 14, Withdrawn 12, Suspended 4, Enrolling by invitation 1
Phase 4211Completed 111, Unknown 35, Terminated 22, Recruiting 18, Not yet recruiting 8, Withdrawn 8, Active not recruiting 6, Enrolling by invitation 2, Suspended 1
Early Phase 1113Recruiting 26, Completed 25, Unknown 17, Terminated 16, Withdrawn 11, Active not recruiting 10, Not yet recruiting 8

Follow Pancreatic Diseases: new trials by email Literature Review of Pancreatic Diseases trials Research Report on Pancreatic Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Certepetide Phase 1b/2a Continuous Infusion Trial in mPDAC
certepetide, nab-paclitaxel, gemcitabine - Pancreas Cancer, Pancreatic Carcinoma
Phase 1 / Phase 2WithdrawnLisata Therapeutics, Inc.2030-01-012025-06-06
Endoscopic Ultrasound-Guided Pulsed Electric Field Ablation for the Treatment of Pancreatic Neoplasms
Clinical Intervention or Procedure, Electronic Health Record Review, Endoscopic Ultrasound-Guided Fine-Needle Aspiration of the Pancreas - Pancreatic Neoplasm, Pancreatic Neuroendocrine Tumor
Not applicableEnrolling by invitationOhio State University Comprehensive Cancer Center122027-10-012026-10-13
Intermittent Fasting for Pancreatitis
Intermittent Fasting, No intermittent fasting - Pancreatitis, Pancreatitis, Acute
Not applicableNot yet recruitingH. Lee Moffitt Cancer Center and Research Institute642027-09-012026-09-17
Ampligen Combined With SOC Versus SOC Alone Following First-Line Therapy in Subjects With LAPC
Rintatolimod - Pancreatic Cancer
Phase 2SuspendedAIM ImmunoTech Inc.902027-08-012026-08-19
VR Pilot for Pancreatitis
Gut Directed VR, Sham Control VR - Chronic Pancreatitis, Recurrent Pancreatitis
Not applicableNot yet recruitingCedars-Sinai Medical Center202027-07-222026-08-05
Clinical Trial of DN022150 Combined With AG Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer With KRAS G12D Mutation
DN022150+AG( Stage I ), DN022150+AG(Stage II), placebo+AG(Stage II) - Pancreatic Cancer, Pancreatic Carcinoma
Phase 2 / Phase 3Not yet recruitingJiangxi Kvvit Pharmaceutical Co., Ltd.4652027-06-062026-06-18
Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a (Trastuzumab Deruxtecan), for Advanced Pancreatic Ductal Adenocarcinoma
Biospecimen Collection, Diagnostic Imaging Testing, Echocardiography Test - Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma
Phase 1 / Phase 2RecruitingNational Cancer Institute (NCI)312027-06-012026-10-22
Daraxonrasib in Resectable PDAC
Daraxonrasib, Surgical Resection, Adjuvant Chemotherapy - Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer
Phase 1Not yet recruitingDana-Farber Cancer Institute302027-04-132026-10-27
A Phase I/IIa Study of EF-009 in Patients With Pancreatic Cancer
EF-009 - Pancreatic Cancer
Phase 1 / Phase 2Not yet recruitingEverfront Biotech Co., Ltd.302027-04-012026-09-11
A Prospective Study of Concurrent Hyperthermia, Chemotherapy and Radiotherapy in Borderline and Locally Advanced Pancreatic Cancer (PANHEAT)
Hyperthermia plus neoadjuvant chemotherapy/radiotherapy Arm Description: Hyperthermia plus neoadjuvant chemotherapy (mFOLFIRINOX/nab Paclitaxel) followed by a) surgically resectable: Hyp - Borderline and Locally Advanced Pancreatic Cancer
Not applicableNot yet recruitingFernando Pessoa Canarias University602027-03-312026-09-24
A Trial of the Arctx Cool Catheter in Acute Pancreatitis
Treatment, Control - Acute Pancreatitis (AP)
Not applicableNot yet recruitingArctx Medical, Inc.2002027-02-012026-09-03
A Study of Perioperative Navlimetostat Combined With Modified FOLFIRINOX in Patients With MTAP-Deleted Pancreatic Cancer
Navlimetostat, mFOLFIRINOX Treatment Regimen - Pancreatic Ductal Adenocarcinoma (PDAC)
Phase 1 / Phase 2Not yet recruitingDaniel Nussbaum, M.D.182027-01-152026-11-02
Predicting Pancreatic Fistula After Pancreatic Surgery Using Preoperative Immunity
blood sampling - Pancreatic Cancer
Not yet recruitingInstitut Paoli-Calmettes3102027-01-042026-09-18
TRANScriptional Pathways Of Surgical Pain Modulated by Music Therapy Exposure (TRANSPOSE)
Music-assisted relaxation and imagery (MARI) - Surgery, Stomach Cancer
Not applicableNot yet recruitingCase Comprehensive Cancer Center202027-01-012026-08-05
Pharmacokinetics of CFTR Modulators in Pregnant Individuals and in Postpartum Breastfeeding Mothers
Cystic Fibrosis, Pregnancy
Not yet recruitingUniversity of Minnesota302027-01-012026-01-20
Vilastobart+Retifanlimab in BRCA or PALB2 Deficient PC
vilastobart (XTX101), Retifanlimab - Pancreatic Cancer Metastatic
Phase 2Not yet recruitingMassachusetts General Hospital402027-01-012026-08-14
Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
Endothelial cell collection - Obesity and Obesity-related Medical Conditions, Diabetes
RecruitingBettina Mittendorfer1002027-01-012026-05-07
Global Utilization And Registry Database for Improved preservAtion of doNor Pancreata (GUARDIAN-PANCREAS)
PancreasPak - Pancreas (Including SPK) Transplantation, Pancreas Diseases
Not yet recruitingParagonix Technologies10002027-01-012026-09-28
A Study Comparing MRG004A Plus Best Supportive Care Versus Placebo and Best Supportive Care in the Treatment of Patients With Advanced Pancreatic Cancer
MRG004A plus best supportive care, Placebo plus best supportive care - Advanced Pancreatic Cancer
Phase 3Not yet recruitingLepu Biopharma Co., Ltd.2312027-01-012026-05-15
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Pancreatic Cancer
Pancreatic Cancer, Advanced or Metastatic
Not yet recruitingUniversity of Maryland, Baltimore4502027-01-012026-11-06

Showing 20 of 6466. Sign in to see all of them.

Narrower conditions

Pancreatic Neoplasms (3684)  ·  Cystic Fibrosis (1584)  ·  Pancreatitis (490)  ·  Colorectal Neoplasms (432)  ·  Stomach Neoplasms (400)  ·  Breast Neoplasms (371)  ·  Neoplasms (339)  ·  Ovarian Neoplasms (297)  ·  Carcinoma, Non-Small-Cell Lung (284)  ·  Lung Neoplasms (284)  ·  Pancreatitis, Chronic (262)  ·  Colonic Neoplasms (254)  ·  Esophageal Neoplasms (243)  ·  Neoplasm Metastasis (238)  ·  Prostatic Neoplasms (194)

Broader conditions

Digestive System Diseases (6424)  ·  Endocrine System Diseases (3978)  ·  Neoplasms by Site (3912)  ·  Endocrine Gland Neoplasms (3878)  ·  Digestive System Neoplasms (3872)  ·  Neoplasms (3695)  ·  Respiratory Tract Diseases (2081)  ·  Lung Diseases (2047)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1702)  ·  Infant, Newborn, Diseases (1620)  ·  Genetic Diseases, Inborn (1616)  ·  Pathological Conditions, Signs and Symptoms (1252)  ·  Neoplasms by Histologic Type (959)  ·  Pathologic Processes (935)

Interventions

Gemcitabine (702)  ·  130-nm albumin-bound paclitaxel (213)  ·  Fluorouracil (200)  ·  Oxaliplatin (181)  ·  Albumin-Bound Paclitaxel (164)  ·  Capecitabine (147)  ·  Leucovorin (139)  ·  Irinotecan (117)  ·  ivacaftor (109)  ·  Radiotherapy (98)  ·  pembrolizumab (89)  ·  Taxes (83)  ·  Cisplatin (82)  ·  Radiosurgery (73)  ·  Erlotinib Hydrochloride (71)

Sponsors

National Cancer Institute (NCI) (128)  ·  Vertex Pharmaceuticals Incorporated (118)  ·  Changhai Hospital (81)  ·  M.D. Anderson Cancer Center (68)  ·  Mayo Clinic (58)  ·  Memorial Sloan Kettering Cancer Center (54)  ·  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (54)  ·  Fudan University (50)  ·  Peking Union Medical College Hospital (50)  ·  Assistance Publique - Hôpitaux de Paris (47)  ·  Massachusetts General Hospital (43)  ·  Ruijin Hospital (40)  ·  Hospices Civils de Lyon (39)  ·  Washington University School of Medicine (38)  ·  H. Lee Moffitt Cancer Center and Research Institute (36)

Countries

United States (2908)  ·  China (751)  ·  France (529)  ·  United Kingdom (445)  ·  Canada (393)  ·  Germany (366)  ·  Italy (350)  ·  Spain (328)  ·  Australia (244)  ·  Belgium (235)  ·  South Korea (223)  ·  Netherlands (217)  ·  Denmark (146)  ·  Israel (135)  ·  Japan (109)

Top investigators

Shyam Varadarajulu, MD (14)  ·  Saleh K Saleh, MD (12)  ·  Felix Ratjen, MD (9)  ·  Margaret Rosenfeld, MD, MPH (8)

Results publications

PMID 37983082, PMID 33331662, PMID 39863139, PMID 33735508, PMID 37319354, PMID 32671834, PMID 37598000, PMID 21561347, PMID 23100216, PMID 23433878, PMID 24054878, PMID 24131140, PMID 27009167, PMID 28040257, PMID 28733257, PMID 31215818, PMID 32761612, PMID 33337539, PMID 36509366, PMID 36511181, PMID 15273542, PMID 15855973, PMID 16003309, PMID 21420083, PMID 22494121, PMID 23547081, PMID 23896955, PMID 25981758, PMID 29889111, PMID 33331663, PMID 36866921, PMID 40056080, PMID 42836590, PMID 12518122, PMID 12806612, PMID 15065835, PMID 15908661, PMID 17981197, PMID 18494054, PMID 18992248, PMID 19410035, PMID 19670912, PMID 19717485, PMID 20189503, PMID 20211892, PMID 20410514, PMID 20620274, PMID 20842054, PMID 21831266, PMID 21963957

NIH funding

2017 (30), 2016 (27), 2018 (25), 2019 (25), 2023 (25), 2014 (23), 2015 (22), 2008 (14), P30CA006973 (14), P30CA016672 (14), P30CA033572 (14), 2009 (12), 2025 (12), P30CA015083 (11), P30CA068485 (10)